Clinical Success of Indirect Pulp Capping: 1-Year Follow-Up

NCT ID: NCT06325540

Last Updated: 2025-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2024-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare the clinical success of theracal pt, therabase, and biodentine indirect pulp capping on primary molars with deep dentin caries. Indirect pulp capping was used on the primary molars of the participants with deep dentin caries. It is aimed to compare the success of biodentine, which is considered the gold standard used in capping treatments, and the currently marketed Teracal PT and Therabase materials after 1, 6 months and 1 year, with biodentine and with each other, and find out which material is more successful.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study utilized a parallel group, randomized controlled design and enrolled patients who visited the Department of Pediatric Dentistry, Health Sciences University, İstanbul, Turkey, in the period of 2020-2022. The study protocol was approved by the Health Sciences University Hamidiye Clinical Research Ethics Committee (7/34).

All procedures were conducted in accordance with the ethical standards of the relevant national and institutional committees on human experimentation with the Helsinki Declaration of 1975, as revised in 2013. The parents or legal guardians provided written in formed consent.

The sample size was calculated using a G\*Power program (G\*power 3.1 version) for the distribution of the success rates in the Biodentine, Therabase and TheraCal PT groups regarding the follow-up periods, the following parameters were used: medium effect size f 0.34, error = 0.05, minimum 80% power. Based on these parameters, the total sample size was calculated as 28 participants for each group.

This study was conducted as a prospective clinical and radiographic evaluation. A total of 76 teeth (first and second primary molars) from 5- to 9-year-old healthy and cooperative children with nonclinical and radiographic evidence of infection symptoms and with indications for indirect pulp treatment were included in this study. The teeth were divided into three groups according to the pulp capping materials.

Inclusion and exclusion criteria:

Healthy patients aged 5-9 years were recruited from the pediatric dental clinic at Health Sciences University. Based on the clinical and radiographic examinations, the inclusion criteria were previously untreated first and second primary molars in cooperative children with good general health, which had deep dentin caries involving occluso-proximal surfaces but showed positive response to vitality tests (electrical pulp test and cold stimulation) (Endo Ice, Hygienic; Coltene/Whaledent AG, Altst€atten, Switzerland and Diagnostic Unit; SybronEndo, Orange, CA); were radiographically detected with caries penetration involving approximately 3/4 of the dentin thickness; were considered to have a potential to result in pulp exposure when the entire caries was cleared according to the complete excavation procedure in which the end point of carious tissue removal is the hard dentin; and showed a moderate response to chemical and thermal stimuli. Clinical success criteria were as follows: signs of irreversible pulpitis (such as spontaneous pain, prolonged pain response), presence of percussion or palpation, pathological mobility, infectious symptoms such as fistula or abscess, and discoloration in the clinical examination. Radiographic success criteria included presence of radiolucency in the furcation or periapical regions, thickening of the periodontal spaces, and internal or external root resorption.

Clinical practice:

Two pediatric dentists screened each patient for inclusion and exclusion criteria during a preoperative oral examination and participants that met the inclusion criteria were randomly divided into three groups: Biodentine group (n =25), TheraCal PT group (n=26), Therabase group (n =25).

Following the application of topical and local anaesthesia injection (2% lidocaine hydrochloride with epinephrine 1:80,000; Septodont, Saint-Maur-des-Fosses, France), rubber-dam isolation (Dental Dam, Coltène Whaledent, Langenau, Germany) were performed. The tooth was disinfected by scrubbing with 2% chlorhexidine. The carious peripheral dentin was removed using a high-speed dental diamond bur (Dentsply, Dentsply Maillefer, Baillaigues, Switzerland) and the infected and necrotic soft dentin layer in the center was carefully removed to prevent pulp exposure. Cavity excavation was stopped when the residual dentin over the pulp tissue showed increased resistance to manual instrumentation, and the demineralized dentin (affected dentin) was left at the floor of the cavity. After removal of carious, the cavities were washed with 2% chlorhexidine gluconate irrigation solution (Klorhex, Drogsan, Türkiye) and then were dried with an air-water spray and cotton pellets. Biodentine, TheraCal PT and Therabase materials were applied according to the manufacturer's instructions.

Biodentine group: The entire residual demineralized dentin tissue covered with approximately 1mm tricalcium silicate pulp-capping material, Biodentine (Septodont,Saint-Maur-des-Fossés,France) by avoiding the placement of the material on enamel or margins of the cavity. After application of Biodentin, 12-min setting time was allowed for setting, in accordance with the recommendations of the manufacturer.

Theracal PT group: The entire residual demineralized dentin tissue covered with maximum thickness of 1mm flowable form of resin-modified calcium silicate-containing material, (TheraCal PT,Bisco Inc.,Schaumburg,IL,USA) by avoiding the placement of the material on enamel or margins of the cavity. After appllication of TheraCal PT, the polymerization for 20s (Elipar Deep Cure; 3 M ESPE, St. Paul, MN, USA), in accordance with the recommendations of the manufacturer.

Therabase group: The entire residual demineralized dentin tissue covered with maximum thickness of 1mm flowable form of dual-cured, calcium and fluoride releasing, self-adhesive base/liner material Therabase (Therabase PT,Bisco Inc.,Schaumburg,IL,USA) by avoiding the placement of the material on enamel or margins of the cavity. After appllication of TheraCal PT, the polymerization for 20s (Elipar Deep Cure; 3 M ESPE, St. Paul, MN, USA) in accordance with the recommendations of the manufacturer.

Afterwards, in all three groups, glass ionomer cement consisting of powder and liquid (Ketac Molar Easy Mix 3M ESPE, Germany) was placed on each capping material. Following the etching and bonding process, permanent restoration was finished with composite resin (Filtek Z250 Universal Restorative System, 3M ESPE DentalProducts, USA).

Clinical and radiographic examination: The patients were called for follow-up at 1 months, 6 months and 1 year during the first year. At each follow-up visit, a clinical examination was performed to assess the presence of tenderness to percussion or palpation, spontaneous pain or prolonged pain response, discoloration, infectious symptoms such as fistula or abscess, and pathological mobility. Additionally, a radiographic examination was performed to assess the presence of lesions in the furcation or periapical regions, internal or external root resorption, and thickening of the periodontal spaces. The teeth detected with at least one of these findings were considered 'unsuccessful.'

Statistical analysis All statistical analyses were performed by using software (SPSS, IBM SPSS Statistics 2022). Normality and homegenity of the data were evaluated by using Kolmogorov-Smirnov and Levene's Homogeneity tests. Pearson chi-square and Kruskall-Wallis H tests were performed to analyze data at the 95% confidence level (P = 0.05).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentin, Carious Indirect Pulp Capping

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Indirect pulp capping will be applied to primary molar teeth with deep dentin caries in 3 groups with 3 different materials(biodentine, thermal pt, therabase).
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
patients and the researcher who evaluates the follow-up results of the patients will not know which material was used for indirect pulp coating.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

theracal pt

Teeth treated with indirect pulp capping with theracal pt

Group Type EXPERIMENTAL

indirect pulp capping with theracal pt

Intervention Type PROCEDURE

indirect pulp capping using the theracal pt material

therabase

Teeth treated with indirect pulp capping with therabase

Group Type EXPERIMENTAL

indirect pulp capping with therabase

Intervention Type PROCEDURE

indirect pulp capping using the therabase material

biodentine

Teeth treated with indirect pulp capping with biodentine

Group Type ACTIVE_COMPARATOR

indirect pulp capping with biodentine

Intervention Type PROCEDURE

indirect pulp capping using the biodentine material

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

indirect pulp capping with theracal pt

indirect pulp capping using the theracal pt material

Intervention Type PROCEDURE

indirect pulp capping with therabase

indirect pulp capping using the therabase material

Intervention Type PROCEDURE

indirect pulp capping with biodentine

indirect pulp capping using the biodentine material

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy children aged 5-9 years
* Previously untreated first and second primary molars with deep caries
* First and second primary molar teeth with positive pulpal response in vitality tests
* Primary molar teeth with radiographically detected caries involving approximately ¾ of the dentin thickness
* Primary molar teeth with the potential for pulp exposure according to the procedure in which the carious tissue is completely removed

Exclusion Criteria

* Teeth showing signs of irreversible pulpitis (spontaneous pain, no prolonged pain response)
* Teeth with symptoms of pain on percussion or palpation
* Teeth with pathological mobility
* Teeth with infectious symptoms such as fistula or abscess
* Teeth showing discoloration on clinical examination
* Radiolucency observed in the periapical region or furcation on radiographic examination
Minimum Eligible Age

5 Years

Maximum Eligible Age

9 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saglik Bilimleri Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

şükriye türkoğlu kayacı

Role: STUDY_DIRECTOR

Saglik Bilimleri Universitesi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sağlık Bilimleri Üniversitesi

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

pulpcapping

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.